Read further: Trans-Fatty Acids Drive Atherosclerosis through Sphingolipid Metabolism and VLDL Secretion
VISUALIZED: Trans-Fatty Acids Drive Atherosclerosis through Sphingolipid Metabolism and VLDL Secretion
You may also like
Real-World Effectiveness of Nirsevimab in Preventing...
Comparison of Hypotension-Avoidance and Hypertension...
Increased Cardiac Mortality in Massachusetts During...
Tracking Early Cardiac Development: Insights from Live...
Cardiac Digital Twins: Advancing Personalized Insights...
Portfolio Diet Reduces CVD Mortality and Risk Factors...
About the author
